Skip to main content
Erschienen in: Breast Cancer Research and Treatment 3/2018

20.12.2017 | Epidemiology

Mammography use among women aged 18–39 years in the United States

verfasst von: Jin Qin, Mary C. White, Susan A. Sabatino, Isaedmarie Febo-Vázquez

Erschienen in: Breast Cancer Research and Treatment | Ausgabe 3/2018

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Recommendations for breast cancer screening using mammography target asymptomatic women aged ≥ 40 years who are not at increased risk for breast cancer. Evidence is not available to demonstrate benefits of screening with mammography at younger ages, and little is known about mammography use among younger women. This study described mammography use among women aged 18–39 years.

Methods

We analyzed data from the 2011–2015 National Survey of Family Growth, an in-person survey of a nationally representative sample of the U.S. household population. We estimated the prevalence of ever receiving a mammogram and examined reasons for the first mammograms among women aged 18–39 years without personal cancer history (n = 8324). We classified the first mammogram as a screening examination if it was performed either as part of a routine exam or because of family history of cancer.

Results

Among women aged 18–39 years, 14.3% (95% CI 13.2–15.4) reported ever having a mammogram. Prevalence of mammography use was highest among women aged 35–39 years (31.0%, 95% CI 27.8–34.5), and was higher among non-Hispanic black women than in other race/ethnicity groups. Women with a family history of breast cancer reported a higher prevalence of mammography use than women without this family history. For both women with and without a family history of breast cancer, about half of all first mammograms were performed for screening reasons.

Conclusions

Among U.S. women aged 18–39 years with no personal cancer history, one in seven reported having received a mammogram. Women with no family history of breast cancer were as likely as those with a family history to initiate breast cancer screening with mammography before age 40. Our findings provide evidence that supports further research to examine factors that prompt young women to receive screening mammograms.
Literatur
3.
Zurück zum Zitat Oeffinger KC, Fontham ET, Etzioni R, Herzig A, Michaelson JS, Shih YC, Walter LC, Church TR, Flowers CR, LaMonte SJ, Wolf AM, DeSantis C, Lortet-Tieulent J, Andrews K, Manassaram-Baptiste D, Saslow D, Smith RA, Brawley OW, Wender R, American Cancer S (2015) Breast cancer screening for women at average risk: 2015 guideline update from the American Cancer Society. JAMA 314(15):1599–1614CrossRefPubMedPubMedCentral Oeffinger KC, Fontham ET, Etzioni R, Herzig A, Michaelson JS, Shih YC, Walter LC, Church TR, Flowers CR, LaMonte SJ, Wolf AM, DeSantis C, Lortet-Tieulent J, Andrews K, Manassaram-Baptiste D, Saslow D, Smith RA, Brawley OW, Wender R, American Cancer S (2015) Breast cancer screening for women at average risk: 2015 guideline update from the American Cancer Society. JAMA 314(15):1599–1614CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Siu AL (2016) Screening for Breast Cancer: U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med 164(4):279–296CrossRefPubMed Siu AL (2016) Screening for Breast Cancer: U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med 164(4):279–296CrossRefPubMed
6.
Zurück zum Zitat United States Cancer Statistics: 1999–2013 Incidence, WONDER Online Database. United States Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute (2016) http://wonder.cdc.gov/cancer-v2013.html. Accessed 25 Sept 2017 United States Cancer Statistics: 1999–2013 Incidence, WONDER Online Database. United States Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute (2016) http://​wonder.​cdc.​gov/​cancer-v2013.​html. Accessed 25 Sept 2017
7.
Zurück zum Zitat Saslow D, Boetes C, Burke W, Harms S, Leach MO, Lehman CD, Morris E, Pisano E, Schnall M, Sener S, Smith RA, Warner E, Yaffe M, Andrews KS, Russell CA, American Cancer Society Breast Cancer Advisory G (2007) American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin 57(2):75–89CrossRefPubMed Saslow D, Boetes C, Burke W, Harms S, Leach MO, Lehman CD, Morris E, Pisano E, Schnall M, Sener S, Smith RA, Warner E, Yaffe M, Andrews KS, Russell CA, American Cancer Society Breast Cancer Advisory G (2007) American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin 57(2):75–89CrossRefPubMed
8.
Zurück zum Zitat International Agency for Research on Cancer (2015) IARC handbooks of cancer prevention. In: Breast cancer screening, vol 15. IARC Press, Lyon, France International Agency for Research on Cancer (2015) IARC handbooks of cancer prevention. In: Breast cancer screening, vol 15. IARC Press, Lyon, France
9.
Zurück zum Zitat Nelson HD, Pappas M, Cantor A, Griffin J, Daeges M, Humphrey L (2016) Harms of breast cancer screening: systematic review to update the 2009 U.S. Preventive Services Task Force Recommendation. Ann Intern Med 164(4):256–267CrossRefPubMed Nelson HD, Pappas M, Cantor A, Griffin J, Daeges M, Humphrey L (2016) Harms of breast cancer screening: systematic review to update the 2009 U.S. Preventive Services Task Force Recommendation. Ann Intern Med 164(4):256–267CrossRefPubMed
10.
Zurück zum Zitat Schonberg MA, Breslau ES, McCarthy EP (2013) Targeting of mammography screening according to life expectancy in women aged 75 and older. J Am Geriatr Soc 61(3):388–395CrossRefPubMedPubMedCentral Schonberg MA, Breslau ES, McCarthy EP (2013) Targeting of mammography screening according to life expectancy in women aged 75 and older. J Am Geriatr Soc 61(3):388–395CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Tan A, Kuo YF, Elting LS, Goodwin JS (2013) Refining physician quality indicators for screening mammography in older women: distinguishing appropriate use from overuse. J Am Geriatr Soc 61(3):380–387CrossRefPubMedPubMedCentral Tan A, Kuo YF, Elting LS, Goodwin JS (2013) Refining physician quality indicators for screening mammography in older women: distinguishing appropriate use from overuse. J Am Geriatr Soc 61(3):380–387CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Tan A, Kuo YF, Goodwin JS (2014) Potential overuse of screening mammography and its association with access to primary care. Med Care 52(6):490–495CrossRefPubMedPubMedCentral Tan A, Kuo YF, Goodwin JS (2014) Potential overuse of screening mammography and its association with access to primary care. Med Care 52(6):490–495CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Lepkowski JM, Mosher WD, Davis KE, Groves RM, Van Hoewyk J (2013) Responsive design, weighting, and variance estimation in the 2006–2010 National Survey of Family Growth. National Center for Health Statistics. Vital Health Stat 2(158):1–52 Lepkowski JM, Mosher WD, Davis KE, Groves RM, Van Hoewyk J (2013) Responsive design, weighting, and variance estimation in the 2006–2010 National Survey of Family Growth. National Center for Health Statistics. Vital Health Stat 2(158):1–52
15.
Zurück zum Zitat Lepkowski JM, Mosher WD, Davis KE, Groves RM, Van Hoewyk J (2010) The 2006–2010 National Survey of Family Growth: sample design and analysis of a continuous survey. National Center for Health Statistics. Vital Health Stat 2(150):1–36 Lepkowski JM, Mosher WD, Davis KE, Groves RM, Van Hoewyk J (2010) The 2006–2010 National Survey of Family Growth: sample design and analysis of a continuous survey. National Center for Health Statistics. Vital Health Stat 2(150):1–36
16.
Zurück zum Zitat Groves RM, Mosher WD, Lepkowski J, Kirgis NG (2009) Planning and development of the continuous National Survey of Family Growth. National Center for Health Statistics. Vital Health Stat 1(48):1–64 Groves RM, Mosher WD, Lepkowski J, Kirgis NG (2009) Planning and development of the continuous National Survey of Family Growth. National Center for Health Statistics. Vital Health Stat 1(48):1–64
18.
Zurück zum Zitat Barnett JC, Marina SV (2016) Current Population Reports, P60-257(RV), Health Insurance Coverage in the United States: 2015. U.S. Government Printing Office, Washington, DC Barnett JC, Marina SV (2016) Current Population Reports, P60-257(RV), Health Insurance Coverage in the United States: 2015. U.S. Government Printing Office, Washington, DC
19.
Zurück zum Zitat Ward BW, Clarke TC, Nugent CN, Schiller JS (2016) Early release of selected estimates based on data from the 2015 National Health Interview Survey. National Center for Health Statistics. http://www.cdc.gov/nchs/nhis.htm. Accessed 16 Mar 2017 Ward BW, Clarke TC, Nugent CN, Schiller JS (2016) Early release of selected estimates based on data from the 2015 National Health Interview Survey. National Center for Health Statistics. http://​www.​cdc.​gov/​nchs/​nhis.​htm. Accessed 16 Mar 2017
21.
Zurück zum Zitat Lee CH, Dershaw DD, Kopans D, Evans P, Monsees B, Monticciolo D, Brenner RJ, Bassett L, Berg W, Feig S, Hendrick E, Mendelson E, D’Orsi C, Sickles E, Burhenne LW (2010) Breast cancer screening with imaging: recommendations from the Society of Breast Imaging and the ACR on the use of mammography, breast MRI, breast ultrasound, and other technologies for the detection of clinically occult breast cancer. J Am Coll Radiol 7(1):18–27CrossRefPubMed Lee CH, Dershaw DD, Kopans D, Evans P, Monsees B, Monticciolo D, Brenner RJ, Bassett L, Berg W, Feig S, Hendrick E, Mendelson E, D’Orsi C, Sickles E, Burhenne LW (2010) Breast cancer screening with imaging: recommendations from the Society of Breast Imaging and the ACR on the use of mammography, breast MRI, breast ultrasound, and other technologies for the detection of clinically occult breast cancer. J Am Coll Radiol 7(1):18–27CrossRefPubMed
22.
Zurück zum Zitat Yankaskas BC, Haneuse S, Kapp JM, Kerlikowske K, Geller B, Buist DS, Breast Cancer Surveillance C (2010) Performance of first mammography examination in women younger than 40 years. J Natl Cancer Inst 102(10):692–701CrossRefPubMedPubMedCentral Yankaskas BC, Haneuse S, Kapp JM, Kerlikowske K, Geller B, Buist DS, Breast Cancer Surveillance C (2010) Performance of first mammography examination in women younger than 40 years. J Natl Cancer Inst 102(10):692–701CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Kapp JM, Ryerson AB, Coughlin SS, Thompson TD (2009) Racial and ethnic differences in mammography use among U.S. women younger than age 40. Breast Cancer Res Treat 113(2):327–337CrossRefPubMed Kapp JM, Ryerson AB, Coughlin SS, Thompson TD (2009) Racial and ethnic differences in mammography use among U.S. women younger than age 40. Breast Cancer Res Treat 113(2):327–337CrossRefPubMed
24.
Zurück zum Zitat Scharpf TP, Rimm AA (2006) Mammography utilization rates among young white and black women in the USA. Public Health 120(10):937–941CrossRefPubMed Scharpf TP, Rimm AA (2006) Mammography utilization rates among young white and black women in the USA. Public Health 120(10):937–941CrossRefPubMed
25.
Zurück zum Zitat White A, Thompson TD, White MC, Sabatino SA, de Moor J, Doria-Rose PV, Geiger AM, Richardson LC (2017) Cancer screening test use—United States, 2015. MMWR Morb Mortal Wkly Rep 66(8):201–206CrossRefPubMedPubMedCentral White A, Thompson TD, White MC, Sabatino SA, de Moor J, Doria-Rose PV, Geiger AM, Richardson LC (2017) Cancer screening test use—United States, 2015. MMWR Morb Mortal Wkly Rep 66(8):201–206CrossRefPubMedPubMedCentral
26.
Zurück zum Zitat Joslyn SA, Foote ML, Nasseri K, Coughlin SS, Howe HL (2005) Racial and ethnic disparities in breast cancer rates by age: NAACCR Breast Cancer Project. Breast Cancer Res Treat 92(2):97–105CrossRefPubMed Joslyn SA, Foote ML, Nasseri K, Coughlin SS, Howe HL (2005) Racial and ethnic disparities in breast cancer rates by age: NAACCR Breast Cancer Project. Breast Cancer Res Treat 92(2):97–105CrossRefPubMed
27.
29.
Zurück zum Zitat Kohler BA, Sherman RL, Howlader N, Jemal A, Ryerson AB, Henry KA, Boscoe FP, Cronin KA, Lake A, Noone AM, Henley SJ, Eheman CR, Anderson RN, Penberthy L (2015) Annual Report to the Nation on the Status of Cancer, 1975-2011, featuring incidence of breast cancer subtypes by race/ethnicity, poverty, and state. J Natl Cancer Inst 107(6):djv048CrossRefPubMedPubMedCentral Kohler BA, Sherman RL, Howlader N, Jemal A, Ryerson AB, Henry KA, Boscoe FP, Cronin KA, Lake A, Noone AM, Henley SJ, Eheman CR, Anderson RN, Penberthy L (2015) Annual Report to the Nation on the Status of Cancer, 1975-2011, featuring incidence of breast cancer subtypes by race/ethnicity, poverty, and state. J Natl Cancer Inst 107(6):djv048CrossRefPubMedPubMedCentral
30.
Zurück zum Zitat El-Tamer MB, Song M, Wait RB (1999) Breast masses in African American teenage girls. J Pediatr Surg 34(9):1401–1404CrossRefPubMed El-Tamer MB, Song M, Wait RB (1999) Breast masses in African American teenage girls. J Pediatr Surg 34(9):1401–1404CrossRefPubMed
31.
Zurück zum Zitat Littrup PJ, Freeman-Gibb L, Andea A, White M, Amerikia KC, Bouwman D, Harb T, Sakr W (2005) Cryotherapy for breast fibroadenomas. Radiology 234(1):63–72CrossRefPubMed Littrup PJ, Freeman-Gibb L, Andea A, White M, Amerikia KC, Bouwman D, Harb T, Sakr W (2005) Cryotherapy for breast fibroadenomas. Radiology 234(1):63–72CrossRefPubMed
32.
Zurück zum Zitat Rauscher GH, Johnson TP, Cho YI, Walk JA (2008) Accuracy of self-reported cancer-screening histories: a meta-analysis. Cancer Epidemiol Biomark Prev 17(4):748–757CrossRef Rauscher GH, Johnson TP, Cho YI, Walk JA (2008) Accuracy of self-reported cancer-screening histories: a meta-analysis. Cancer Epidemiol Biomark Prev 17(4):748–757CrossRef
Metadaten
Titel
Mammography use among women aged 18–39 years in the United States
verfasst von
Jin Qin
Mary C. White
Susan A. Sabatino
Isaedmarie Febo-Vázquez
Publikationsdatum
20.12.2017
Verlag
Springer US
Erschienen in
Breast Cancer Research and Treatment / Ausgabe 3/2018
Print ISSN: 0167-6806
Elektronische ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-017-4625-6

Weitere Artikel der Ausgabe 3/2018

Breast Cancer Research and Treatment 3/2018 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.